on the boundary of significanceP = 0.058
An improved OS on the boundary of significance was also observed (83.8 vs. 72.8%, HR, 0.54, 95% CI, 0.29–1.03, P = 0.058).
An improved OS on the boundary of significance was also observed (83.8 vs. 72.8%, HR, 0.54, 95% CI, 0.29–1.03, P = 0.058).
The administration of paclitaxel, cisplatin and 5-fluorouracil regimen was also associated with better BRFS (HR, 0.27, 95% CI, 0.10–0.75, P = 0.007), PFS (HR, 0.60, 95% CI, 0.42–0.87, P = 0.007), and OS with borderline significance (HR, 0.54, 95% CI, 0.29–1.03, P = 0.058).